Tunkel AR, Glaser CA, Bloch KC, et al; Infectious Diseases Society of America. The management of encephalitis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis. 2008;47:303-327.
Venkatesan A, Tunkel AR, Bloch KC, et al. Case definitions, diagnostic algorithms, and priorities in encephalitis: consensus statement of the International Encephalitis Consortium. Clin Infect Dis. 2013;57:1114-1128.
Vora NM, Holman RC, Mehal JM, et al. Burden of encephalitis-associated hospitalizations in the United States, 1998-2010. Neurology. 2014;82:443-451.
Kneen R, Michael BD, Menson E, et al; National Encephalitis Guidelines Development and Stakeholder Groups. Management of suspected viral encephalitis in children - Association of British Neurologists and British Paediatric Allergy, Immunology and Infection Group national guidelines. J Infect. 2012;64:449-477.
Solomon T, Michael BD, Smith PE, et al; National Encephalitis Guidelines Development and Stakeholder Groups. Management of suspected viral encephalitis in adults - Association of British Neurologists and British Infection Association national guidelines. J Infect. 2012;64:347-373.
Singh TD, Fugate JE, Rabinstein AA. The spectrum of acute encephalitis: causes, management, and predictors of outcome. Neurology. 2015;84:359-366.
1. Tunkel AR, Glaser CA, Bloch KC, et al; Infectious Diseases Society of America. The management of encephalitis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis. 2008;47:303-327.
2. Venkatesan A, Tunkel AR, Bloch KC, et al. Case definitions, diagnostic algorithms, and priorities in encephalitis: consensus statement of the International Encephalitis Consortium. Clin Infect Dis. 2013;57:1114-1128.
3. Encephalitis Society. Questions and answers. 2008. http://www.encephalitis.info/ (last accessed 3 August 2017).
4. Vora NM, Holman RC, Mehal JM, et al. Burden of encephalitis-associated hospitalizations in the United States, 1998-2010. Neurology. 2014;82:443-451.
5. Granerod J, Ambrose HE, Davies NW, et al. Causes of encephalitis and differences in their clinical presentations in England: a multicentre, population-based prospective study. Lancet Infect Dis. 2010;10:835-844.
6. George BP, Schneider EB, Venkatesan A. Encephalitis hospitalization rates and inpatient mortality in the United States, 2000-2010. PloS One. 2014;9:e104169.
7. Barbadoro P, Marigliano A, Ricciardi A, et al. Trend of hospital utilization for encephalitis. Epidemiol Infect. 2012;140:753-764.
8. Bernard S, Mailles A, Stahl JP, et al. Epidemiology of infectious encephalitis, differences between a prospective study and hospital discharge data. Epidemiol Infect. 2013;141:2256-2268.
9. Huppatz C, Durrheim DN, Levi C, et al. Etiology of encephalitis in Australia, 1990-2007. Emerg Infect Dis. 2009;15:1359-1365.
10. Kulkarni MA, Lecocq AC, Artsob H, et al. Epidemiology and aetiology of encephalitis in Canada, 1994-2008: a case for undiagnosed arboviral agents? Epidemiol Infect. 2013;141:2243-2255.
11. Galanakis E, Tzoufi M, Katragkou A, et al. A prospective multicenter study of childhood encephalitis in Greece. Pediatr Infect Dis J. 2009;28:740-742.
12. Kolski H, Ford-Jones EL, Richardson S, et al. Etiology of acute childhood encephalitis at The Hospital for Sick Children, Toronto, 1994-1995. Clin Infect Dis. 1998;26:398-409.
13. Lee TC, Guo HR, Su HJ, et al. Diseases caused by enterovirus 71 infection. Pediatr Infect Dis J. 2009;28:904-910.
14. Mailles A, Stahl JP; Steering Committee and Investigators Group. Infectious encephalitis in France in 2007: a national prospective study. Clin Infect Dis. 2009;49:1838-1847.
15. Srey VH, Sadones H, Ong S, et al. Etiology of encephalitis syndrome among hospitalized children and adults in Takeo, Cambodia, 1999-2000. Am J Trop Med Hyg. 2002;66:200-207.
16. Gable MS, Sheriff H, Dalmau J, et al. The frequency of autoimmune N-methyl-D-aspartate receptor encephalitis surpasses that of individual viral etiologies in young individuals enrolled in the California Encephalitis Project. Clin Infect Dis. 2012;54:899-904.
17. Cho H, Proll SC, Szretter KJ, et al. Differential innate immune response programs in neuronal subtypes determine susceptibility to infection in the brain by positive-stranded RNA viruses. Nat Med. 2013;19:458-464.
18. Srinivasan A, Burton EC, Kuehnert MJ, et al. Transmission of rabies virus from an organ donor to four transplant recipients. N Engl J Med. 2005;352:1103-1111.
19. Venkatesan A, Geocadin RG. Diagnosis and management of acute encephalitis: a practical approach. Neurol Clin Pract. 2014;4:206-215.
20. Britton PN, Eastwood K, Paterson B, et al. Consensus guidelines for the investigation and management of encephalitis in adults and children in Australia and New Zealand. Intern Med J. 2015;45:563-576.
21. Pöllabauer EM, Pavlova BG, Löw-Baselli A, et al. Comparison of immunogenicity and safety between two paediatric TBE vaccines. Vaccine. 2010;28:4680-4685.
22. Prymula R, Pöllabauer EM, Pavlova BG, et al. Antibody persistence after two vaccinations with either FSME-IMMUN® Junior or ENCEPUR® Children followed by third vaccination with FSME-IMMUN® Junior. Hum Vaccin Immunother. 2012;8:736-742.
23. Demicheli V, Debalini MG, Rivetti A. Vaccines for preventing tick-borne encephalitis. Cochrane Database Syst Rev. 2009;(1):CD000977.
24. Fischer M, Lindsey N, Staples JE, et al; Centers for Disease Control and Prevention (CDC). Japanese encephalitis vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2010;59:1-27.
25. MacNeil JR, Rubin L, Folaranmi T, et al. Use of serogroup B meningococcal vaccines in adolescents and young adults: recommendations of the Advisory Committee on Immunization Practices, 2015. MMWR Morb Mortal Wkly Rep. 2015;64:1171-1176.
26. Australian Technical Advisory Group on Immunisation. Advice for immunisation providers regarding the use of Bexsero® - a recombinant multicomponent meningococcal B vaccine (4CMenB). March 2014. http://www.immunise.health.gov.au/ (last accessed 1 August 2017).
27. Hsu HE, Shutt KA, Moore MR, et al. Effect of pneumococcal conjugate vaccine on pneumococcal meningitis. N Engl J Med. 2009;360:244-256.
28. Gelfand JM, Genrich G, Green AJ, et al. Encephalitis of unclear origin diagnosed by brain biopsy: a diagnostic challenge. JAMA Neurol. 2015;72:66-72.
29. Wilson MR, Naccache SN, Samayoa E, et al. Actionable diagnosis of neuroleptospirosis by next-generation sequencing. N Engl J Med. 2014;370:2408-2417.
30. Sanchez-Juan P, Green A, Ladogana A, et al. CSF tests in the differential diagnosis of Creutzfeldt-Jakob disease. Neurology. 2006;67:637-643.
31. Sano K, Satoh K, Atarashi R, et al. Early detection of abnormal prion protein in genetic human prion diseases now possible using real-time QUIC assay. PLoS One. 2013;8:e54915.
32. Glaser CA, Honarmand S, Anderson LJ, et al. Beyond viruses: clinical profiles and etiologies associated with encephalitis. Clin Infect Dis. 2006;43:1565-1577.
33. Lai CW, Gragasin ME. Electroencephalography in herpes simplex encephalitis. J Clin Neurophysiol. 1988;5:87-103.
34. Gutierrez J, Issacson RS, Koppel BS. Subacute sclerosing panencephalitis: an update. Dev Med Child Neurol. 2010;52:901-907.
35. Westmoreland BF. The EEG in cerebral inflammatory processes. In: Niedermeyer E, Lopes Da Silva F, eds. Electroencephalography. 4th ed. Baltimore, MD: Williams and Wilkins; 1999:302-316.
36. Jakob NJ, Lenhard T, Schnitzler P, et al. Herpes simplex virus encephalitis despite normal cell count in the cerebrospinal fluid. Crit Care Med. 2012;40:1304-1308.
37. Mook-Kanamori B, van de Beek D, Wijdicks EF. Herpes simplex encephalitis with normal initial cerebrospinal fluid examination. J Am Geriatr Soc. 2009;57:1514-1515.
38. Weil AA, Glaser CA, Amad Z, et al. Patients with suspected herpes simplex encephalitis: rethinking an initial negative polymerase chain reaction result. Clin Infect Dis. 2002;34:1154-1157.
39. Fodor PA, Levin MJ, Weinberg A, et al. Atypical herpes simplex virus encephalitis diagnosed by PCR amplification of viral DNA from CSF. Neurology. 1998;51:554-559.
40. De Biasi RL, Tyler KL. Viral meningitis and encephalitis. Continuum: Lifelong Learn Neurol. 2006;12:36.
41. Chaudhuri A, Kennedy PG. Diagnosis and treatment of viral encephalitis. Postgrad Med J. 2002;78:575-583.
42. Schraeder PL, Burns RA. Hemiplegic migraine associated with an aseptic meningeal reaction. Arch Neurol. 1980;37:377-379.
43. Feely MP, O'Hare J, Veale D, et al. Episodes of acute confusion or psychosis in familial hemiplegic migraine. Acta Neurol Scand. 1982;65:369-375.
44. Chakrapani A, Cleary MA, Wraith JE. Detection of inborn errors of metabolism in the newborn. Arch Dis Child Fetal Neonatal Ed. 2001;84:F205-F210.
45. Burton BK. Inborn errors of metabolism in infancy: a guide to diagnosis. Pediatrics. 1998;102:e69.
46. Tunkel AR, Hartman BJ, Kaplan SL, et al. Practice guidelines for the management of bacterial meningitis. Clin Infect Dis. 2004;39:1267-1284.
47. Greenberg BM. Central nervous system infections in the intensive care unit. Semin Neurol. 2008;28:682-689.
48. Portegies P, Solod L, Cinque P, et al. Guidelines for the diagnosis and management of neurological complications of HIV infection. Eur J Neurol. 2004;11:297-304.
49. Kumar R, Singhi S, Singhi P, et al. Randomized controlled trial comparing cerebral perfusion pressure-targeted therapy versus intracranial pressure-targeted therapy for raised intracranial pressure due to acute CNS infections in children. Crit Care Med. 2014;42:1775-1787.
50. Whitley RJ, Alford CA, Hirsch MS, et al. Vidarabine versus acyclovir therapy in herpes simplex encephalitis. N Engl J Med. 1986;314:144-149.
51. Kneen R, Michael BD, Menson E, et al; National Encephalitis Guidelines Development and Stakeholder Groups. Management of suspected viral encephalitis in children - Association of British Neurologists and British Paediatric Allergy, Immunology and Infection Group national guidelines. J Infect. 2012;64:449-477.
52. Solomon T, Michael BD, Smith PE, et al; National Encephalitis Guidelines Development and Stakeholder Groups. Management of suspected viral encephalitis in adults - Association of British Neurologists and British Infection Association national guidelines. J Infect. 2012;64:347-373.
53. Beckham JD, Tyler KL. Encephalitis. In: Mandell GL, Bennett JE, Dolin R, eds. Mandell, Douglas, and Bennett’s principles and practice of infectious diseases. 7th ed. Philadelphia, PA: Churchill Livingstone; 2010.
54. Steiner I, Budka H, Chaudhuri A, et al. Viral meningoencephalitis: a review of diagnostic methods and guidelines for management. Eur J Neurol. 2010;17:999-e57.
55. Yan HJ. Herpes simplex encephalitis: the role of surgical decompression. Surg Neurol. 2002;57:20-24.
56. Dalmau J, Lancaster E, Martinez-Hernandez E, et al. Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis. Lancet Neurol. 2011;10:63-74.
57. McKeon A. Paraneoplastic and other autoimmune disorders of the central nervous system. Neurohospitalist. 2013;3:53-64.
58. Titulaer MJ, McCracken L, Gabilondo I, et al. Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study. Lancet Neurol. 2013;12:157-165.
59. Cohen O, Steiner-Birmanns B, Biran I, et al. Recurrence of acute disseminated encephalomyelitis at the previously affected brain site. Arch Neurol. 2001;58:797-801.
60. Vedeler CA, Antoine JC, Giometto B, et al. Management of paraneoplastic neurological syndromes: report of an EFNS Task Force. Eur J Neurol. 2006;13:682-690.
61. Moorthi S, Schneider WN, Dombovy ML. Rehabilitation outcomes in encephalitis - a retrospective study 1990-1997. Brain Inj. 1999;13:139-146.
62. Steiner I, Budka H, Chaudhuri A, et al. Viral encephalitis: a review of diagnostic methods and guidelines for management. Eur J Neurol. 2005;12:331-343.
63. Lane-Brown AT, Tate RL. Apathy after acquired brain impairment: a systematic review of non-pharmacological interventions. Neuropsychol Rehabil. 2009;19:481-516.
64. Pöhlmann C, Schetelig J, Reuner U, et al. Cidofovir and foscarnet for treatment of Human Herpes Virus 6 encephalitis in a neutropenic stem cell transplant recipient. Clin Infect Dis. 2007;44:e118-e120.
65. Meyer Sauteur PM, Jacobs BC, Spuesens EB, et al. Antibody responses to Mycoplasma pneumoniae: role in pathogenesis and diagnosis of encephalitis? PLoS Pathog. 2014;10:e1003983.
66. Sköldenberg B, Aurelius E, Hjalmarsson A, et al. Incidence and pathogenesis of clinical relapse after herpes simplex encephalitis in adults. J Neurol. 2006;253:163-170.
67. Habel AH, Brown JK. Dexamethasone in herpes-simplex encephalitis. Lancet. 1972;1:695.
68. Upton AR, Foster JB, Barwick DD. Dexamethasone treatment in herpes-simplex encephalitis. Lancet. 1971;1:861.
69. Kamei S, Sekizawa T, Shiota H, et al. Evaluation of combination therapy using aciclovir and corticosteroid in adult patients with herpes simplex virus encephalitis. J Neurol Neurosurg Psychiatry. 2005;76:1544-1549.
70. Martinez-Torres F, Menon S, Pritsch M, et al; GACHE Investigators. Protocol for German trial of acyclovir and corticosteroids in herpes-simplex-virus-encephalitis (GACHE): a multicenter, multinational, randomized, double-blind, placebo-controlled German, Austrian and Dutch trial [ISRCTN45122933]. BMC Neurol. 2008;8:40.
71. Ben-Nathan D, Gershoni-Yahalom O, Samina I, et al. Using high titer West Nile intravenous immunoglobulin from selected Israeli donors for treatment of West Nile virus infection. BMC Infect Dis. 2009;9:18.
72. Singh TD, Fugate JE, Rabinstein AA. The spectrum of acute encephalitis: causes, management, and predictors of outcome. Neurology. 2015;84:359-366.
73. Granerod J, Tam CC, Crowcroft NS, et al. Challenge of the unknown: a systematic review of acute encephalitis in non-outbreak situations. Neurology. 2010;75:924-932.
74. Thakur KT, Motta M, Asemota AO, et al. Predictors of outcome in acute encephalitis. Neurology. 2013;81:793-800.
75. Michaeli O, Kassis I, Shachor-Meyouhas Y, et al. Long-term motor and cognitive outcome of acute encephalitis. Pediatrics. 2014;133:e546-e552.
76. McJunkin JE, Khan R, de los Reyes EC, et al. Treatment of severe La Crosse encephalitis with intravenous ribavirin following diagnosis by brain biopsy. Pediatrics. 1997;99:261-267.
77. Fowler A, Stödberg T, Eriksson M, et al. Childhood encephalitis in Sweden: etiology, clinical presentation and outcome. Eur J Paediatr Neurol. 2008;12:484-490.
78. Elbers JM, Bitnun A, Richardson SE, et al. A 12-year prospective study of childhood herpes simplex encephalitis: is there a broader spectrum of disease? Pediatrics. 2007;119:e399-e407.
79. Annegers JF, Hauser WA, Beghi E, et al. The risk of unprovoked seizures after encephalitis and meningitis. Neurology. 1988;38:1407-1410.
80. Singh TD, Fugate JE, Hocker SE, et al. Postencephalitic epilepsy: clinical characteristics and predictors. Epilepsia. 2015;56:133-138.
81. McGrath N, Anderson NE, Croxson MC, et al. Herpes simplex encephalitis treated with acyclovir: diagnosis and long term outcome. J Neurol Neurosurg Psychiatry. 1997;63:321-326.
82. Mailles A, De Broucker T, Costanzo P, et al; Steering Committee and Investigators Group. Long-term outcome of patients presenting with acute infectious encephalitis of various causes in France. Clin Infect Dis. 2012;54:1455-1464.
83. Chou IC, Lin CC, Kao CH. Enterovirus encephalitis increases the risk of attention deficit hyperactivity disorder: a Taiwanese population-based case-control study. Medicine (Baltimore). 2015;94:e707.
84. Behan PO, Bakheit AM. Clinical spectrum of postviral fatigue syndrome. Br Med Bull. 1991;47:793-808.
85. Pradhan S, Pandey N, Shashank S, et al. Parkinsonism due to predominant involvement of substantia nigra in Japanese encephalitis. Neurology. 1999;53:1781-1786.
使用此内容应接受我们的免责声明。
BMJ临床实践的持续改进离不开您的帮助和反馈。如果您发现任何功能问题和内容错误,或您对BMJ临床实践有任何疑问或建议,请您扫描右侧二维码并根据页面指导填写您的反馈和联系信息*。一旦您的建议在我们核实后被采纳,您将会收到一份小礼品。
如果您有紧急问题需要我们帮助,请您联系我们。
邮箱:bmjchina.support@bmj.com
电话:+86 10 64100686-612
*您的联系信息仅会用于我们与您确认反馈信息和礼品事宜。
BMJ临床实践官方反馈平台